Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Getting Companies To Discuss Their Pediatric Research Plans Early: EMA Pilot Finally Gets Off To A Start

This article was originally published in SRA

Executive Summary

Interest is finally to beginning to pick up in the European Medicines Agency's pilot project on offering early scientific advice to drug sponsors to support the development of pediatric medicines. The pilot had initially drawn a lukewarm response from pharmaceutical companies, who showed reluctance to discuss their pediatric research plans with the agency at an early stage.

Advertisement

Related Content

Parallel EMA-FDA Pediatric Advice On The Cards For Companies
Advertisement
UsernamePublicRestriction

Register

PS118414

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel